CTOs on the Move

MacuLogix

www.maculogix.com

 
MacuLogix is the only company to leverage the science of dark adaptation to help eliminate preventable blindness caused by AMD.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.maculogix.com
  • 1801 Oberlin Road Suite 301
    Middletown, PA USA 17057
  • Phone: 717.914.4067

Executives

Name Title Contact Details

Funding

MacuLogix raised $10M on 07/18/2018
MacuLogix raised $38.7M on 03/04/2019

Similar Companies

Delic Corporation

DELIC was formed in 2019 to address the growing interest in psychedelic wellness backed by science. DELIC was the first psychedelic umbrella platform and is currently a trusted source for those interested in psychedelic culture, psychedelic clinics, and more. DELIC`s offerings include, Ketamine Infusion Center (under binding acquisition agreement), a limited liability corporation formed under the laws of Arizona and runs two ketamine clinics in Arizona and California, "Reality Sandwich", a free public education platform providing psychedelic guides, news and culture, "Meet Delic", the first ever psychedelic wellness summit, and "The Delic", an e-commerce lifestyle brand.

bioTheranostics

bioTheranostics is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OrthoHelix Surgical Designs

OrthoHelix Surgical Designs is a Medina, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CeQur

CeQur is dedicated to helping people with type 2 diabetes manage their disease by developing and commercializing simple drug delivery devices that can be easily integrated into daily life. The company`s lead product, PaQ, is a wearable insulin delivery device that delivers both basal and bolus insulin for 3 days at a time. Its simple, discreet design enables people to easily experience the benefits of intensive insulin therapy, while remaining free from the burdens of daily insulin injections. CeQur SA was established in January 2008 as a spinout from Danfoss A/S, a global Danish industrial products group that developed the initial concept of the CeQur technology. CeQur recently completed a clinical study evaluating PaQ among people with type 2 diabetes with positive results. The company has advanced the technology to a commercial product obtaining a CE mark for PaQ in 2012. CeQur is headquartered in Horw, Switzerland, with operations in Nordborg, Denmark and Marlborough, Massachusetts.